Millie D Long

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. pmc Suboptimal rates of cervical testing among women with inflammatory bowel disease
    Millie D Long
    Division of Gastroenterology and Hepatology, University of North Carolina Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
    Clin Gastroenterol Hepatol 7:549-53. 2009
  2. pmc Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease
    Millie D Long
    Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina 27599 7080, USA
    Clin Gastroenterol Hepatol 8:268-74. 2010
  3. pmc Increased risk of pneumonia among patients with inflammatory bowel disease
    Millie D Long
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
    Am J Gastroenterol 108:240-8. 2013
  4. pmc Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease
    Millie D Long
    Department of Medicine, University of North Carolina, Chapel Hill, NC, USA
    Gastroenterology 143:390-399.e1. 2012
  5. pmc Patient perception of chronic illness care in a large inflammatory bowel disease cohort
    Rachel L Randell
    School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
    Inflamm Bowel Dis 19:1428-33. 2013
  6. pmc The Impact of Ostomy on Quality of Life and Functional Status of Crohn's Disease Patients
    Maisa I Abdalla
    Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina and Department of Pediatrics, Division of Pediatric Gastroenterology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
    Inflamm Bowel Dis 22:2658-2664. 2016
  7. pmc Validation of an internet-based cohort of inflammatory bowel disease (CCFA partners)
    Rachel L Randell
    University of North Carolina School of Medicine, Chapel Hill, North Carolina Center for Gastrointestinal Biology and Disease, and Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Worldwide Epidemiology GlaxoSmithKline, Research Triangle Park, North Carolina Section of Biostatistics and Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire and Division of Gastroenterology and Hepatology, Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina
    Inflamm Bowel Dis 20:541-4. 2014
  8. pmc Increased risk of pneumocystis jiroveci pneumonia among patients with inflammatory bowel disease
    Millie D Long
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
    Inflamm Bowel Dis 19:1018-24. 2013
  9. pmc Hormone replacement therapy, oral contraceptive use, and distal large bowel cancer: a population-based case-control study
    Millie D Long
    Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
    Am J Gastroenterol 105:1843-50. 2010
  10. pmc Inverse relationship between moderate alcohol intake and rectal cancer: analysis of the North Carolina Colon Cancer Study
    Seth D Crockett
    Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA
    Dis Colon Rectum 54:887-94. 2011

Collaborators

Detail Information

Publications40

  1. pmc Suboptimal rates of cervical testing among women with inflammatory bowel disease
    Millie D Long
    Division of Gastroenterology and Hepatology, University of North Carolina Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
    Clin Gastroenterol Hepatol 7:549-53. 2009
    ..We aimed to determine cervical testing rates among women with IBD, specifically those on immunosuppressant medications, and to identify risk factors associated with low incidence of screening...
  2. pmc Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease
    Millie D Long
    Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina 27599 7080, USA
    Clin Gastroenterol Hepatol 8:268-74. 2010
    ..We evaluated the risk of non-melanoma skin cancer (NMSC) in patients with IBD and determined how immunosuppressive and biologic medications affect this risk...
  3. pmc Increased risk of pneumonia among patients with inflammatory bowel disease
    Millie D Long
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
    Am J Gastroenterol 108:240-8. 2013
    ..Patients with inflammatory bowel disease (IBD) may be at increased risk for infections. We aimed to determine the pneumonia risk in IBD and how specific medications affect this risk...
  4. pmc Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease
    Millie D Long
    Department of Medicine, University of North Carolina, Chapel Hill, NC, USA
    Gastroenterology 143:390-399.e1. 2012
    ..Patients with inflammatory bowel disease (IBD) are at risk for certain malignancies. We aimed to determine the risk of melanoma and nonmelanoma skin cancer (NMSC) in patients with IBD and how medications affect these risks...
  5. pmc Patient perception of chronic illness care in a large inflammatory bowel disease cohort
    Rachel L Randell
    School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
    Inflamm Bowel Dis 19:1428-33. 2013
    ....
  6. pmc The Impact of Ostomy on Quality of Life and Functional Status of Crohn's Disease Patients
    Maisa I Abdalla
    Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina and Department of Pediatrics, Division of Pediatric Gastroenterology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
    Inflamm Bowel Dis 22:2658-2664. 2016
    ..We performed this study to evaluate the impact of a long-term ostomy (≥6 mo duration) on the functional status and specific patient-reported outcomes in a population of patients with Crohn's disease (CD)...
  7. pmc Validation of an internet-based cohort of inflammatory bowel disease (CCFA partners)
    Rachel L Randell
    University of North Carolina School of Medicine, Chapel Hill, North Carolina Center for Gastrointestinal Biology and Disease, and Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Worldwide Epidemiology GlaxoSmithKline, Research Triangle Park, North Carolina Section of Biostatistics and Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire and Division of Gastroenterology and Hepatology, Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina
    Inflamm Bowel Dis 20:541-4. 2014
    ..We used a large Internet-based inflammatory bowel disease (IBD) cohort to validate self-reported IBD against physician reports...
  8. pmc Increased risk of pneumocystis jiroveci pneumonia among patients with inflammatory bowel disease
    Millie D Long
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
    Inflamm Bowel Dis 19:1018-24. 2013
    ..Our aims were (1) to determine the incidence and relative risk of PCP in IBD and (2) to describe medication exposures in patients with IBD with PCP...
  9. pmc Hormone replacement therapy, oral contraceptive use, and distal large bowel cancer: a population-based case-control study
    Millie D Long
    Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
    Am J Gastroenterol 105:1843-50. 2010
    ..We aimed to determine the associations between hormone replacement therapy, oral contraceptive use, and distal large bowel cancer...
  10. pmc Inverse relationship between moderate alcohol intake and rectal cancer: analysis of the North Carolina Colon Cancer Study
    Seth D Crockett
    Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA
    Dis Colon Rectum 54:887-94. 2011
    ..The relationship between alcohol intake and rectal cancer is uncertain...
  11. pmc Variation in Care of Inflammatory Bowel Diseases Patients in Crohn's and Colitis Foundation of America Partners: Role of Gastroenterologist Practice Setting in Disease Outcomes and Quality Process Measures
    Kimberly N Weaver
    Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Division of Pediatric Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Center for Gastrointestinal Biology and Disease Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina and Geisel School of Medicine at Dartmouth
    Inflamm Bowel Dis 22:2672-2677. 2016
    ..As variation in care has previously been linked to quality, we aimed to describe variations in inflammatory bowel diseases care by gastroenterology (GI) practice setting...
  12. pmc Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and Answers
    Hans H Herfarth
    Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina CGIBD Biostatistics Core, University of North Carolina, Chapel Hill, North Carolina Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Geisel School of Medicine at Dartmouth, Hanover, New Hampshire Division of Gastroenterology, University of Pennsylvania, Philadelphia, Pennsylvania Dr Henry D Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York Division of Gastroenterology and Hepatology, Michigan, Indiana and Center for Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania
    Inflamm Bowel Dis . 2016
    ..This article provides a framework for the different phases of an IIT and outlines potential hurdles, which could hinder a successful execution...
  13. pmc Medication Utilization and the Impact of Continued Corticosteroid Use on Patient-reported Outcomes in Older Patients with Inflammatory Bowel Disease
    Matthew Geisz
    University of North Carolina at Chapel Hill School of Medicine Department of Medicine, Division of Gastroenterology and Hepatology, University of California, Los Angeles, California Center for Gastrointestinal Biology and Disease, Chapel Hill, North Carolina Department of Pediatrics, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina and Geisel School of Medicine at Dartmouth, Hanover, New Hampshire
    Inflamm Bowel Dis 22:1435-41. 2016
    ..We aimed to describe (1) medication use in older and younger IBD patients and (2) medication associations with patient reported outcomes (PROs) in older patients...
  14. doi request reprint Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners
    Maisa I Abdalla
    Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Department of Medicine, Division of Gastroenterology and Hepatology, Loma Linda University, Loma Linda, California Department of Pediatrics Division of Pediatric Gastroenterology, University of North Carolina, Chapel Hill, North Carolina and Geisel School of Medicine at Dartmouth, Hanover, New Hampshire
    Inflamm Bowel Dis . 2017
    ..Limited data are available on how IBS impacts the individual patient with IBD. In this study, we aimed to evaluate the prevalence of IBD-IBS and investigate its impact on patient-reported outcomes...
  15. pmc Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease
    Millie D Long
    Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC Geisel School of Medicine at Dartmouth, Hanover, NH
    J Clin Gastroenterol 50:152-6. 2016
    ..To determine the role of nonsteroidal anti-inflammatory drugs (NSAIDs) in activation of inflammatory bowel disease (IBD)...
  16. pmc Perceptions of patients with inflammatory bowel diseases on biobanking
    Millie D Long
    Departments of Medicine, and Social Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina GlaxoSmithKline Worldwide Epidemiology, Research Triangle, North Carolina and Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
    Inflamm Bowel Dis 21:132-8. 2015
    ..Little is known about beliefs, understanding, and perceptions of biobanking among patients with inflammatory bowel diseases. We aimed to further understand perceptions of biobanking in the inflammatory bowel disease community...
  17. pmc Risk factors for depression in the elderly inflammatory bowel disease population
    Millie D Long
    University of North Carolina at Chapel Hill, Department of Medicine, Division of Gastroenterology and Hepatology, USA Center for Gastrointestinal Biology and Disease, Chapel Hill, NC, USA Electronic address
    J Crohns Colitis 8:113-9. 2014
    ..We assessed the point prevalence of depression and determined associations with disease activity, quality of life, and medication adherence in elderly patients with IBD...
  18. pmc Nonmelanoma skin cancer in inflammatory bowel disease: a review
    Millie D Long
    Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina Chapel Hill, North Carolina 27599 7080, USA
    Inflamm Bowel Dis 17:1423-7. 2011
    ..We also offer recommendations for prevention of NMSC in these populations...
  19. pmc Exercise decreases risk of future active disease in patients with inflammatory bowel disease in remission
    Patricia D Jones
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Department of Medicine, Center for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina and Division of Gastroenterology and Hepatology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
    Inflamm Bowel Dis 21:1063-71. 2015
    ..Among patients with inflammatory bowel disease in remission, we aimed to evaluate the association between exercise and subsequent active disease...
  20. pmc Prevalence of a gluten-free diet and improvement of clinical symptoms in patients with inflammatory bowel diseases
    Hans H Herfarth
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina and Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina
    Inflamm Bowel Dis 20:1194-7. 2014
    ..Maintaining a gluten-free diet (GFD) without an underlying diagnosis of celiac disease has enjoyed widespread acceptance in the Unites States...
  21. doi request reprint Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results
    Millie D Long
    University of North Carolina, Department of Medicine, Division of Gastroenterology and Hepatology, Chapel Hill, North Carolina 27599, USA
    Inflamm Bowel Dis 18:2099-106. 2012
    ..The widespread use of the Internet allows for unique research opportunities. We aimed to develop and follow an Internet-based cohort (e-cohort) of patients with self-reported inflammatory bowel diseases (IBD) over time...
  22. doi request reprint Colorectal cancer testing in the national Veterans Health Administration
    Millie D Long
    Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Campus Box 7080, Chapel Hill, NC 27599 7080, USA
    Dig Dis Sci 57:288-93. 2012
    ..Colorectal cancer (CRC) screening is a priority for the Veteran's Health Administration (VHA). Optimizing fecal occult blood testing (FOBT) is integral to CRC screening in health care systems...
  23. pmc Harnessing person-generated health data to accelerate patient-centered outcomes research: the Crohn's and Colitis Foundation of America PCORnet Patient Powered Research Network (CCFA Partners)
    Arlene E Chung
    Department of Pediatrics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA Department of Internal Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA Carolina Health Informatics Program, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA
    J Am Med Inform Assoc 23:485-90. 2016
    ....
  24. pmc Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases
    Hans H Herfarth
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina
    Inflamm Bowel Dis 22:224-33. 2016
    ....
  25. pmc Immunization rates and vaccine beliefs among patients with inflammatory bowel disease: an opportunity for improvement
    Sharmeel K Wasan
    Section of Gastroenterology, Department of Medicine, Boston Medical Center, Boston, MA and Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC
    Inflamm Bowel Dis 20:246-50. 2014
    ..Our study aimed to describe vaccine utilization by immunosuppression status, examine reasons for vaccine refusal, and identify characteristics associated with lack of influenza vaccination in patients with IBD...
  26. pmc Narcotic use for inflammatory bowel disease and risk factors during hospitalization
    Millie D Long
    Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
    Inflamm Bowel Dis 18:869-76. 2012
    ..We sought to study the relationship between narcotic use, objective measures of disease activity, and other associated factors in hospitalized patients with IBD...
  27. pmc Impact of capsule endoscopy on management of inflammatory bowel disease: a single tertiary care center experience
    Millie D Long
    University of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology, Chapel Hill, North Carolina 27599 7080, USA
    Inflamm Bowel Dis 17:1855-62. 2011
    ..Capsule endoscopy (CE) is performed to assess inflammatory bowel disease (IBD). We aimed to define the results of CE in subtypes of IBD and to determine whether CE results in management changes...
  28. pmc MicroRNAs Classify Different Disease Behavior Phenotypes of Crohn's Disease and May Have Prognostic Utility
    Bailey C E Peck
    Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Department of Medicine, Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Department of Medicine, Curriculum in Bioinformatics and Computational Biology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Department of Medicine, Center for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Departments of Pathology and Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina and Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
    Inflamm Bowel Dis 21:2178-87. 2015
    ..We examined whether different phenotypes in CD can be classified based on colonic microRNA (miRNA) expression and whether miRNAs have prognostic utility for CD...
  29. pmc Use of Biologics in Pouchitis: A Systematic Review
    Hans H Herfarth
    Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC
    J Clin Gastroenterol 49:647-54. 2015
    ....
  30. pmc Methotrexate: underused and ignored?
    Hans H Herfarth
    Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC 27599, USA hherf med unc edu
    Dig Dis 30:112-8. 2012
    ..This review investigates the potential reasons for the underuse of methotrexate in patients with inflammatory bowel diseases...
  31. pmc Changing shape of disease: nonalcoholic fatty liver disease in Crohn's disease-a case series and review of the literature
    Christopher E McGowan
    Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, 27599 7080, USA
    Inflamm Bowel Dis 18:49-54. 2012
    ..These changes may herald an increase in the incidence of nonalcoholic fatty liver disease (NAFLD) in this population...
  32. pmc Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease
    Millie D Long
    University of North Carolina at Chapel Hill, Department of Medicine, Division of Gastroenterology and Hepatology, Chapel Hill, North Carolina 27599 7080, USA
    Inflamm Bowel Dis 17:2162-8. 2011
    ....
  33. doi request reprint Capsule and balloon endoscopy: When are they really needed in patients with inflammatory bowel diseases?
    Hans H Herfarth
    Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Dig Dis 28:439-44. 2010
    ..This review summarizes the current clinical status of capsule and balloon enteroscopy in patients with suspected or established IBD...
  34. doi request reprint Reduced polyp detection as endoscopy shift progresses: experience with screening colonoscopy at a tertiary-care hospital
    Millie D Long
    Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7080, USA
    J Clin Gastroenterol 45:253-8. 2011
    ..To determine whether polyp detection rates are reduced as time progresses through half and full-day endoscopy shifts...
  35. pmc Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure
    Bharati Kochar
    Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC Division of Gastroenterology and Hepatology, Massachusetts General Hospital Section of Gastroenterology, Boston Medical Center, Boston University School of Medicine, Boston, MA
    J Clin Gastroenterol . 2016
    ..Because of the rarity of SBS, real-world safety or efficacy data are not available in patients with Crohn's disease (CD) and SBS treated with teduglutide...
  36. pmc Hormonal Contraception Use is Common Among Patients with Inflammatory Bowel Diseases and an Elevated Risk of Deep Vein Thrombosis
    Cary C Cotton
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Center for Gastrointestinal Biology and Disease, Chapel Hill, North Carolina and NIH, Epidemiology Branch, National Institute of Environmental Health Sciences, North Carolina
    Inflamm Bowel Dis 22:1631-8. 2016
    ..We sought to examine whether the self-report of hormonal contraception (HC), as a proxy for exposure to estrogen-based contraception, was less common for women with multiple risk factors for venous thromboembolism...
  37. doi request reprint Management of Eosinophilic Esophagitis During Pregnancy
    Caitlin M Burk
    Division of Gastroenterology and Hepatology, Department of Medicine, Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, CB 7080, Bioinformatics Building, 130 Mason Farm Rd, UNC CH, Chapel Hill, NC, 27599 7080, USA
    Dig Dis Sci 61:1819-25. 2016
    ..Providers who care for EoE patients who could become pregnant should familiarize themselves with these issues. ..
  38. pmc The association between diabetes, insulin use, and colorectal cancer among Whites and African Americans
    Lisa C Vinikoor
    University of North Carolina, Chapel Hill, NC 27599 7555, USA
    Cancer Epidemiol Biomarkers Prev 18:1239-42. 2009
    ..No association was present among African Americans. Insulin use was also positively associated with rectal cancer among Whites...
  39. pmc Evaluation of a non-invasive method to detect cytomegalovirus (CMV)-DNA in stool samples of patients with inflammatory bowel disease (IBD): a pilot study
    Hans H Herfarth
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Bioinformatics Bldg, CB 7080, Chapel Hill, NC, 27599, USA
    Dig Dis Sci 55:1053-8. 2010
    ..The aim of this pilot study was to investigate the diagnostic efficacy of quantitative polymerase chain reaction (PCR) to detect CMV DNA in stool samples of IBD patients...
  40. pmc Bone health in a tertiary-care gastroenterology and hepatology population
    Millie D Long
    Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC 27599 7080, USA
    Dig Dis Sci 55:2263-9. 2010
    ..Glucocorticoid use is a major risk factor for osteoporosis. Overall rates of glucocorticoid use and bone health preventive measures in gastroenterology and hepatology populations are unknown...